Trials / Terminated
TerminatedNCT02130401
Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Scion NeuroStim · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is an open-label, proof of concept study with a single active treatment arm designed to assess whether CVS-based stimulation has a beneficial effect on patients with type 2 diabetes. The primary outcome measure is a difference between pre and post-treatment A1c.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TNM Device | The device is worn like a music headset and the patient lies on a wedge pillow while the device is active. Each session lasts under 20 minutes. |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2015-05-01
- Completion
- 2015-06-01
- First posted
- 2014-05-05
- Last updated
- 2025-06-06
- Results posted
- 2025-06-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02130401. Inclusion in this directory is not an endorsement.